Executive Summary Systemic Light Chain (AL) Amyloidosis Market: Growth Trends and Share Breakdown CAGR Value The global systemic light chain (AL) amyloidosis market size was valued at USD 2.59 billion in 2025 and is expected to reach USD 3.68 billion by 2033, at a CAGR of 4.50% during the forecast period The key highlights of this Systemic Light Chain (AL) Amyloidosis Market report are key...

The United States represents a significant market for deferasirox, driven by the growing prevalence of transfusion-dependent blood disorders such as thalassemia, sickle cell disease, and myelodysplastic syndromes. The country benefits from a well-established healthcare infrastructure, advanced diagnostic capabilities, and strong access to specialized hematology treatments. Increasing awareness...